Differential effects of cyclosporin-A on lymphocyte subpopulations.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Transplantation Proceedings

• Publication date

  1981-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 6455796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological effects of cyclosporin A: A new antilymphocytic agent

  2005cited by this paper
• Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

  1980cited by this paper
• Effects of cyclosporin A on the generation of primed lymphocytes in vitro.

  1980cited by this paper
• Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance.

  1980cited by this paper
• Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man

  1979cited by this paper
• CYCLOSPORIN A: AN IMMUNOSUPPRESSIVE AGENT PREFERENTIALLY ACTIVE AGAINST PROLIFERATING T CELLS

  1979cited by this paper
• Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

  1977cited by this paper
• Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.

  1976cited by this paper

• Transplantation of Sertoli-Islet Cell Aggregates Formed by Microgravity: Prolonged Survival in Diabetic Rats

  2009cites this paper
• Cyclosporin A–Immunobiological Aspects

  2007cites this paper
• Formation of insulin-secreting, Sertoli-enriched tissue constructs by microgravity coculture of isolated pig islets and rat Sertoli cells

  2001cites this paper
• Sertoli Cell-Enriched Fractions in Successful Islet Cell Transplantation

  1993cites this paper
• Brief treatment with rapamycin in vivo increases responsiveness to alloantigens measured by the mixed lymphocyte response.

  1992cites this paper
• Soluble IL‐2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy

  1991cites this paper
• Increased T suppressor activity in renal transplant recipients with long‐term stable graft function

  1990cites this paper
• Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis

  1990cites this paper
• Predominance of Mex+ cells in newly-established human lymphoblastoid cell lines.

  1989cites this paper
• Eimeria vermiformis and E. mitis: inhibition of development in vivo by cyclosporin A.

  1989cites this paper
• Penetration of 2% cyclosporin eyedrops into human aqueous humour.

  1989cites this paper
• The effect of cyclosporin A on Trypanosoma musculi infection of mice.

  1988cites this paper
• The effects of immunosuppressive pharmacological agents on the induction of cytotoxic and suppressor T lymphocytes in vitro.

  1988cites this paper
• The effects of immunosuppressive pharmacological agents on the induction of cytotoxic and suppressor T lymphocytes in vitro.

  1988cites this paper
• The Peripheral Nerve Allograft: A Dose-Response Curve in the Rat Immunosuppressed with Cyclosporin A

  1988cites this paper
• Intratesticular islet xenograft survival in relation to tissue cyclosporine levels.

  1988cites this paper
• Evidence of neuro-immunologic interactions: cyclosporine modifies opiate withdrawal by effects on the brain and immune components.

  1987cites this paper
• Experimental vascularized bone allografting

  1987cites this paper
• The role of cyclosporin in prolonging survival in vascularized bone allografts.

  1987cites this paper
• Medical Aspects of Renal Transplantation

  1987cites this paper
• Cyclosporine: Chemistry, Structure-Activity Relationships and Mode of Action

  1986cites this paper
• Cyclosporine affects the function of antigen-presenting cells.

  1986cites this paper
• Immunosuppressive effects of cyclosporin A on cloned T cells.

  1986cites this paper
• Graft Tolerance After Orthotopic Liver Transplantation in a Primarily Nontolerant Strain Combination Following Temporary Cyclosporin A Treatment

  1985cites this paper
• The effect of cyclosporine on cardiac xenograft survival.

  1985cites this paper
• Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum.

  1985cites this paper
• RESTORATION OF T CELL RESPONSIVENESS TO INTERLEUKIN‐2 IN RECIPIENTS OF PANCREATIC ISLET XENOGRAFTS TREATED WITH CYCLOSPORINE

  1985cites this paper
• Clinical and experimental studies with cyclosporine in renal transplantation.

  1985cites this paper
• Effects of cyclosporine in experimental cryptococcal meningitis

  1985cites this paper
• A Single Institution, Randomized, Prospective Trial of Cyclosporine Versus Azathioprine‐Antilymphocyte Globulin for Immunosuppression in Renal Allograft Recipients

  1985cites this paper
• T suppressor cell function in cyclosporine-treated renal transplant recipients.

  1984cites this paper
• Cyclosporine: a powerful addition to the immunosuppressive armamentarium.

  1984cites this paper
• [Cyclosporin: experimental studies and clinical use in organ transplants].

  1984cites this paper
• Mechanisms of Rejection and Prolongation of Vascularized Organ Allografts

  1984cites this paper
• Sparing of suppressor cells: a critical action of cyclosporine.

  1984cites this paper
• [Immunological studies on renal transplantation. III. Experimental studies on the immunosuppressive action of cyclosporin A].

  1984cites this paper
• Cyclosporin A inhibits the delayed-type hypersensitivity effector function of T lymphocytes without affecting their clonal expansion.

  1984cites this paper
• Cyclosporine: Immunology, toxicity and pharmacology in experimental animals

  1984cites this paper
• Use of cyclosporin a in establishing epstein-barr virus-transformed human lymphoblastoid cell lines

  1984cites this paper
• IMMUNOLOGIC REACTIVITY IN MARROW GRAFT RECIPIENTS RECEIVING CYCLOSPORINE TO PREVENT GRAFT‐VERSUS‐HOST DISEASE

  1983cites this paper
• Generation of CFU-c suppressor T cells. VI. Effect of cyclosporin A.

  1983cites this paper
• FUNCTION AND MIGRATION OF SUPPRESSOR LYMPHOCYTES FROM CYCLOSPORINE‐TREATED HEART GRAFT RECIPIENTS

  1983cites this paper
• Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon.

  1983cites this paper
• Cyclosporine: a new and promising immunosuppressive agent.

  1983cites this paper
• Effect of methylprednisolone on human lymphocytes primed to alloantigens.

  1983cites this paper
• PROLONGATION OF SKIN GRAFT SURVIVAL ACROSS DIFFERENT GENETIC BARRIERS IN RATS WITH CYCLOSPORINE—AND ITS POTENTIATION BY BORDETELLA PERTUSSIS VACCINE

  1983cites this paper
• A POTENTIAL SYNERGISTIC EFFECT OF DONOR ANTIGENIC EXTRACTS AND CYCLOSPORINE ON THE PROLONGATION OF RAT RENAL ALLOGRAFTS

  1983cites this paper
• Clinical renal transplantation.

  1983cites this paper
• Immunobiology of cyclosporin A--a review.

  1983cites this paper
• IMMUNOPHARMACOLOGICAL MONITORING OF CYCLOSPORIN A‐TREATED RECIPIENTS OF CADAVERIC KIDNEY ALLOGRAFTS

  1982cites this paper
• Cyclosporin A as a tool for experimental and clinical transplantation.

  1982cites this paper
• Cyclosporin A prevents the appearance of cell surface "activation" antigens.

  1982cites this paper
• Cyclosporin A for Immunosuppression: Observations in Rat Heart, Pancreas, and Islet Allograft Models and in Human Renal and Pancreas Transplantation

  1982cites this paper
• Cyclosporin A: a powerful immunosuppressant.

  1982cites this paper
• Renal transplantation in children.

  1982cites this paper
• Cyclosporin A inhibits ganglioside-stimulated lymphocyte rosette formation in multiple sclerosis.

  1982cites this paper
• Immunosuppressive Treatment in Demyelinating Disease

  1982cites this paper
• Cyclosporin A-immunobiological aspects.

  1982cites this paper
• Cyclosporin A.

  1981cites this paper